Review Article
Risk Factors for Age-Related Maculopathy
Table 8
Studies investigating the relationship between indicators of inflammation and risk for ARM.
| Study | No. of cases | Measure of risk factor | Type of ARM | Odds ratio or relative risk | 95% confidence interval |
| Cross-Sectional Studies | | | | | |
| Atherosclerosis Risk in Communities Study | 11264 | White blood cell count | Early and late ARM | N/A | N/A |
| National Health and Nutrition Examination Survey III [26, 54] | 8270 | Serum albumin | Early ARM | 0.97 | 0.95–1.00 |
|
Cardiovascular Health Study [193] | 2361 | Serum albumin | Early ARM | 0.59 | 0.39–0.92 | Plasma Fibrinogen | Early ARM | N/A | N/A |
|
Cardiovascular Health Study [193] | 2755 | C-reactive protein | Early and Late ARM | 1.24 | 0.87–1.78 (4th Quartile)
|
| Beaver Dam Eye Study [194, 195] | 2764 | Gout | Early ARM | 0.69 | 0.41–1.16 | Late ARM | 2.18 | 1.06–4.47 | Emphysema | Early ARM | 1.11 | 0.49–2.51 | Late ARM | 2.55 | 0.74–8.81 |
| Beaver Dam Eye Study [194, 195] | 3684 | NSAIDs | Early ARM | 1.04 | 0.78–1.38 | Aspirin | Early ARM | 1.08 | 0.79–1.48 | Oral steroids | Early ARM | 0.80 | 0.28–2.28 |
|
Blue Mountains Eye Study [196] | 2313 | Steroids or NSAIDs | Early ARM | 1.2 | 0.8–1.6 | Late ARM | 0.9 | 0.4–1.9 |
| Beaver Dam Eye Study [194, 195] | 2764 | White blood cell count | Early ARM | 1.03 | 0.98–1.10 | Late ARM | 0.99 | 0.86–1.14 | Serum albumin | Early ARM | 0.91 | 0.64–1.29 | Late ARM | 0.52 | 0.24–1.14 |
|
|